China Resources Pharmaceutical Group Limited (3320.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for China Resources Pharmaceutical Group Limited, with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 6.37x |
| P/B Ratio | 0.49x |
| P/S Ratio | 0.10x |
| Profitability | |
| Gross Margin | 16.5% |
| Operating Margin | 4.6% |
| Net Margin | 1.5% |
| EBITDA Margin | 6.1% |
| Liquidity | |
| Current Ratio | 1.42x |
| Quick Ratio | 1.11x |
| Leverage | |
| Debt/Equity | 1.83x |
YoY = year-over-year change. Source: FMP..